C
CTMX
Cytomx Therapeutics Inc
4.560
0.0000.00%After Hours: 4.557 -0.003 -0.07%19:31 04/02 EDT
OPEN/PREV CLOSE4.320/4.400
TODAY RANGE4.145-4.360
VOL6.27M
MARKET CAP929.56M
52 WEEK RANGE0.4000-8.21
AVG VOL (3M)6.73M
% TURNOVER2.90%
TURNOVER--
P/E (TTM)-29.1131
% RANGE4.89%
EPS(TTM)-0.1477
P/E(FORWARD)-8.9583
P/B7.39
BVPS0.5818
DIVIDEND--
P/S9.60
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP867.52M
SHARES OUTSTANDING216.18M
NEXT EARNINGS05/11-05/15
FREE FLOAT201.75M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·5d ago
CytomX Therapeutics Signals Progress in Varseta-M Trial
Dow Jones·03/23 17:01
CytomX Therapeutics Price Target Raised to $12.00/Share From $10.00 by Piper Sandler
Dow Jones·03/23 17:01
CytomX Therapeutics Is Maintained at Overweight by Piper Sandler
TipRanks·03/23 15:07
3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts
TipRanks·03/23 10:55
CytomX Therapeutics price target raised to $12 from $10 at Piper Sandler
Simply Wall St·03/20 16:14
How Investors Are Reacting To CytomX Therapeutics (CTMX) Equity Raise And Encouraging Varseta-M Trial Data
TipRanks·03/20 02:06
Top CytomX Executives Quietly Unload Shares in a Wave of Insider Selling
TipRanks·03/19 20:33
CytomX Therapeutics Raises $234 Million in Equity Offering
Benzinga·03/19 17:05
12 Health Care Stocks Moving In Thursday's Intraday Session
Dow Jones·03/19 14:35
CytomX Therapeutics Is Maintained at Overweight by Barclays
Benzinga·03/19 14:25
Barclays Maintains Overweight on CytomX Therapeutics, Raises Price Target to $16
Reuters·03/19 10:37
CYTOMX THERAPEUTICS <CTMX.O>: BARCLAYS RAISES TARGET PRICE TO $16 FROM $10
Same Industry
Name/Symbol
Change%
Price